Alpha Financial Partners’s AbbVie ABBV Stock Holding History

Alpha Financial Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$498K	Buy	1,978 +203	+11%	+$43.7K	0.26%	63
2026 Q1	$386K	Sell	1,775 -23	-1%	-$5.1K	0.23%	65
2025 Q4	$411K	Buy	1,798 +7	+0.4%	+$1.59K	0.25%	59
2025 Q3	$415K	Buy	1,791 +172	+11%	+$35K	0.27%	54
2025 Q2	$301K	Sell	1,619 -37	-2%	-$6.88K	0.22%	65
2025 Q1	$347K	Buy	1,656 +126	+8%	+$24.5K	0.28%	50
2024 Q4	$272K	Buy	+1,530	New	+$281K	0.22%	57
2024 Q3	–	Sell	-1,808	Closed	-$310K	–	109
2024 Q2	$310K	Buy	1,808 +139	+8%	+$23K	0.27%	44
2024 Q1	$304K	Buy	1,669 +2	+0.1%	+$345	0.28%	43
2023 Q4	$258K	Sell	1,667 -797	-32%	-$116K	0.25%	54
2023 Q3	$367K	Buy	2,464 +2	+0.1%	+$294	0.43%	40
2023 Q2	$332K	Buy	2,462 +26	+1%	+$3.81K	0.35%	56
2023 Q1	$388K	Sell	2,436 -33	-1%	-$5.04K	0.44%	42
2022 Q4	$399K	Buy	+2,469	New	+$379K	0.48%	40

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Alpha Financial Partners's ABBV Position: Q2 2026 in Review

Alpha Financial Partners increased its AbbVie (ABBV) stake by 11% in Q2 2026, buying an estimated $43.7K and bringing the position to 1,978 shares worth $498K. The position accounts for 0.26% of the portfolio, ranked #63.

Alpha Financial Partners first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Alpha Financial Partners held 1,978 shares of AbbVie worth $498K as of Q2 2026.
Alpha Financial Partners bought 203 AbbVie shares in Q2 2026, an estimated $43.7K.
AbbVie made up 0.26% of Alpha Financial Partners's portfolio in Q2 2026, its #63 holding.
Alpha Financial Partners first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Alpha Financial Partners's 13F filing for Q2 2026, filed 11 Aug 2026.